Safety and Efficacy of Racotumomab-alum or Nimotuzumab versus Docetaxel as switch maintenance therapy for advanced non-small cell lung cancer patients: a Phase III open label randomized non-inferiority trial.
Hernandez M, Neninger E, Ortiz Ra, Santiesteban E, C. K, Amador Rm, Cala M, Bello L, Flores Y, Corella M, A. S, J. Y., Mendoza Ic, Viada C, Robaina M, Valenzuela C, Crombet T, Lage A
{"title":"Safety and Efficacy of Racotumomab-alum or Nimotuzumab versus Docetaxel as switch maintenance therapy for advanced non-small cell lung cancer patients: a Phase III open label randomized non-inferiority trial.","authors":"Hernandez M, Neninger E, Ortiz Ra, Santiesteban E, C. K, Amador Rm, Cala M, Bello L, Flores Y, Corella M, A. S, J. Y., Mendoza Ic, Viada C, Robaina M, Valenzuela C, Crombet T, Lage A","doi":"10.15761/gos.1000230","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73175,"journal":{"name":"Global surgery (London)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global surgery (London)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/gos.1000230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
